Cytokinetics CYTK
NASDAQ CYTK
$56.18 +1.04 (+1.89%)
At close: Nov 10, 2026 · 4:00 PM EST

Cytokinetics (CYTK) Preferred Dividend Payments (2011 - 2012)

Updated

Cytokinetics' Preferred Dividend Payments was $1.31 million in FY2012, down 54.3% from $2.86 million in FY2011.

Analysis

Cytokinetics (CYTK) Preferred Dividend Payments (2011 - 2012) Analysis & Trends

  • Per Business Quant data, Preferred Dividend Payments in earlier years was $2.86 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Cytokinetics 7.81 Bn 3.81 Bn 47.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 1.31 Mn
Jun 30, 2011 2.86 Mn
API Access

Cytokinetics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=CYTK&period=max&api_key=YOUR_API_KEY